Limited systemic sclerosis (CREST syndrome)

Last updated: December 18, 2025

Limited systemic sclerosis (CREST syndrome)

Spring 21 Unit 7

Spring 21 Unit 7

Brain herniation
Diabetic nephropathy
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Myocardial infarction
ECG cardiac infarction and ischemia
DALY and QALY
Atherosclerosis and arteriosclerosis: Pathology review
Insulins
Miscellaneous hypoglycemics
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes insipidus
Diabetes mellitus: Clinical
Diabetic retinopathy
Urinary incontinence
Plasma anion gap
Hypoglycemics: Insulin secretagogues
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Thrombolytics
Antiplatelet medications
Ischemic stroke
Dizziness and vertigo: Clinical
Stroke: Clinical
Cerebellum
Vertigo
Zollinger-Ellison syndrome
MEN syndromes: Clinical
Multiple endocrine neoplasia: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Acid reducing medications
Pancreatic neuroendocrine neoplasms
Peptic ulcer
Peptic ulcers and stomach cancer: Clinical
Ulcerative colitis
Helicobacter pylori
Coronary artery disease: Pathology review
Heart blocks: Pathology review
Peripheral artery disease: Pathology review
Ventricular fibrillation
Wolff-Parkinson-White syndrome
Inflammation
Lupus nephritis
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Raynaud phenomenon
Sjogren syndrome: Clinical
Sjogren syndrome
Scleroderma
Limited systemic sclerosis (CREST syndrome)
Vitamin D
Parathyroid conditions and calcium imbalance: Clinical
Class II antiarrhythmics: Beta blockers
Class I antiarrhythmics: Sodium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Long QT syndrome and Torsade de pointes
Calcium channel blockers
Horner syndrome
Cervix and vagina histology
Urinary incontinence: Pathology review
Rubella virus
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Sjogren syndrome: Clinical
Osteoarthritis
Seronegative arthritis: Clinical
Joint pain: Clinical
Systemic lupus erythematosus (SLE): Pathology review
Anatomy of the blood supply to the brain
Cerebral circulation

Flashcards

Limited systemic sclerosis (CREST syndrome)

0 of 12 complete

Transcript

Watch video only

CREST syndrome, also known as limited cutaneous systemic sclerosis, is an autoimmune condition, and its name is an acronym that stands for calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasias.

Calcinosis is the deposition of calcium in the skin, Raynaud’s is spasm of the arteries in the fingers, esophageal dysmotility refers to difficulty swallowing, sclerodactyly is tightening of the skin over the fingers, and telangiectasias are small dilated blood vessels on the skin surface.

So, normally, when there’s an infection in the body, macrophages will eat some of the invading organisms and break them down.

In addition to destroying the pathogen, they also present a fragment of the pathogen, called an antigen, to naive T cells.

When the naive T-cells bind to this presented antigen, they mature into T-helper cells, also called CD4+ T-cells, and go on to help and recruit more immune cells.

The T-helper cells release cytokines, which increase the activity of macrophages and attract nearby neutrophils.

They also release cytokines, like TGF-β, that tells fibroblasts to repair damaged tissue after the infection by laying down collagen.

The cause of CREST syndrome isn’t known exactly, but individuals in the first two years of the disease have a higher than normal number of T-helper cells in the skin on their hands and face, particularly near small blood vessels.

The T-helper cells release cytokines to attract other immune cells, like macrophages and neutrophils, which cause a lot of inflammation in the skin.

There is so much inflammation that the tissue dies, in a process called necrosis.

When the cells die, calcium in the cytosol binds to fragments of cell membrane and builds up in the skin, which is called calcinosis.

It’s not clear why it happens, but individuals with CREST often experience Raynaud’s phenomenon, which is an episodic, dramatic vasoconstriction of arterial blood vessels in the hands.

It’s not quite clear what is going on, but in CREST syndrome there is often difficulty in swallowing food, which we esophageal dysmotility.

The inflammation in the skin, also damages the blood vessels, which eventually results in poor blood flow, called ischemia.

This causes more damage to the skin, particularly in the hands and fingers.

The severe ischemia and tight skin in the fingers can cause ischemic ulcers and even finger loss if left untreated.

The body tries to repair the damage by activating fibroblasts which lay down bundles of collagen.

Key Takeaways

CREST syndrome, also known as the limited cutaneous form of systemic sclerosis is a multisystem connective tissue disorder. The acronym "CREST" refers to the five main features: calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia. It is associated with detectable antibodies against centromeres, and usually spares the kidneys. If the lungs are involved, it is usually in the form of pulmonary arterial hypertension.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Epidemiology of systemic sclerosis" Current Opinion in Rheumatology (2012)
  6. "The Immune Pathogenesis of Scleroderma: Context Is Everything" Current Rheumatology Reports (2012)
  7. "Pathogenesis and treatment modalities of localized scleroderma" Medicina (2010)